Cytocore Inc (CYOE) Inventory Turnover Ratio, from third quarter 2014 to third quarter 2013, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Cytocore Inc  (CYOE)
 

Cytocore Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2014, Cytocore Inc's inventory turnover ratio sequentially decreased to 1.09 in the third quarter 2014, otherwise the ratio remained above the average, as CYOE's markets remain strong.Cytocore Inc's average inventory processing period in the Sep 30 2014 quarter, has increased to 335 days, from 302 days, in the Jun 30 2014 quarter.

Within Healthcare sector Cytocore Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2014 compared to previous quarter at no. .

CYOE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cytocore Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYOE Inventory Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth 119700 % - - -80 % -97.44 %
Inventory Turnover Ratio (TTM) 1.09 1.21 - - -
CYOE's Total Ranking # # # # #
Average inventory processing period 336 302 - - -
Seq. Inventory Growth 3.56 % - - - -
Seq. Cost of Sales Growth -16.86 % - - 0 % -




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



CYOE Company Profile >> Back to CYOE Efficiency Comparisons >> Compare CYOE Inventory Turnover Ratio to its Competitors

Financial Statements
Cytocore Inc's Inventories $ 5 Millions Visit CYOE's Balance sheet
Cytocore Inc's Cost of Revenues TTM $ 3 Millions Visit CYOE's Income Statement
What are CYOE's Sales? Visit CYOE's Sales by Segment

Other Inventory Turnover Ratios
Cytocore Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CYOE's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CYOE's Competitors
Inventory Turnover Ratio for CYOE's Suppliers
Inventory Turnover Ratio for CYOE's Customers

You may also want to know
CYOE's Sales Growth Rates CYOE's Pe Price to earnings ratio CYOE's Receivables Turnover Ratio CYOE's Stock Quote
CYOE's Net Income Growth Rates CYOE's Ps Price to Sales ratio CYOE's Sales per Employee CYOE's Asset Turnover Ratio
CYOE's Net Margin CYOE's Pb Price to Book ratio CYOE's Financial Strength Ratios CYOE's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2014 Inventories at quarter ending Sep 30 2014
Misonix Inc   1.47 $ 6.175  Millions$ 4  Millions
Cyclo Therapeutics Inc   1.46 $ 0.441  Millions$ 0  Millions
Mettler toledo International Inc   1.44 $ 315.526  Millions$ 220  Millions
Skinvisible Inc   1.39 $ 0.061  Millions$ 0  Millions
Regeneron Pharmaceuticals Inc   1.38 $ 133.440  Millions$ 97  Millions
Alexion Pharmaceuticals Inc   1.37 $ 175.975  Millions$ 128  Millions
Dyax Corp  1.37 $ 4.407  Millions$ 3  Millions
Oragenics Inc   1.36 $ 0.358  Millions$ 0  Millions
Trivascular Technologies, Inc.  1.35 $ 10.500  Millions$ 8  Millions
Nephros Inc   1.35 $ 0.211  Millions$ 0  Millions
Cellular Biomedicine Group Inc   1.33 $ 0.251  Millions$ 0  Millions
Zogenix Inc   1.31 $ 19.483  Millions$ 15  Millions
Xtant Medical Holdings Inc   1.30 $ 13.893  Millions$ 11  Millions
Gt Biopharma Inc   1.29 $ 0.044  Millions$ 0  Millions
Asensus Surgical Inc   1.28 $ 0.660  Millions$ 1  Millions
Protalix Biotherapeutics inc   1.27 $ 9.028  Millions$ 7  Millions
Zoetis Inc   1.27 $ 1,692.000  Millions$ 1,333  Millions
Rti Surgical Holdings Inc   1.24 $ 133.496  Millions$ 107  Millions
Nuvasive Inc  1.24 $ 186.552  Millions$ 150  Millions
Quantrx Biomedical Corporation  1.24 $ 0.002  Millions$ 0  Millions
Inergetics Inc  1.19 $ 1.033  Millions$ 1  Millions
Camp4 Therapeutics Corporation  1.15 $ 18.032  Millions$ 16  Millions
Pfizer Inc  1.11 $ 6,875.000  Millions$ 6,209  Millions
Amgen Inc   1.10 $ 3,239.000  Millions$ 2,956  Millions
Axogen inc   1.07 $ 3.642  Millions$ 3  Millions
Celgene Corp  1.06 $ 375.500  Millions$ 355  Millions
Delcath Systems Inc   1.01 $ 0.619  Millions$ 1  Millions
Cv Sciences Inc   1.00 $ 3.579  Millions$ 4  Millions
International Stem Cell Corporation  0.95 $ 1.366  Millions$ 1  Millions
Cumberland Pharmaceuticals Inc   0.92 $ 6.024  Millions$ 7  Millions

Date modified: 2026-09-08T15:07:44+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.